ReShape Lifesciences Inc. (RSLS)
USD 0.46
(0.78%)
USD 0.46
(0.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 262 Thousand USD | 53.22% |
| 2022 | 171 Thousand USD | -38.71% |
| 2021 | 279 Thousand USD | -41.51% |
| 2020 | 477 Thousand USD | -37.89% |
| 2019 | 768 Thousand USD | -87.83% |
| 2018 | 6.31 Million USD | 1191.45% |
| 2017 | 488.61 Thousand USD | 240.04% |
| 2016 | 143.69 Thousand USD | -88.66% |
| 2015 | 1.26 Million USD | -57.43% |
| 2014 | 2.97 Million USD | -56.67% |
| 2013 | 6.86 Million USD | -29.08% |
| 2012 | 9.68 Million USD | 86.65% |
| 2011 | 5.18 Million USD | -12.14% |
| 2010 | 5.9 Million USD | -23.91% |
| 2009 | 7.76 Million USD | -43.23% |
| 2008 | 13.67 Million USD | 23.17% |
| 2007 | 11.09 Million USD | 153.5% |
| 2006 | 4.37 Million USD | -47.52% |
| 2005 | 8.34 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 239 Thousand USD | -8.78% |
| 2024 Q2 | 216 Thousand USD | -9.62% |
| 2023 Q1 | 86 Thousand USD | -49.71% |
| 2023 FY | 262 Thousand USD | 53.22% |
| 2023 Q4 | 262 Thousand USD | -8.07% |
| 2023 Q3 | 285 Thousand USD | -7.17% |
| 2023 Q2 | 307 Thousand USD | 256.98% |
| 2022 Q4 | 171 Thousand USD | -32.94% |
| 2022 Q2 | 338 Thousand USD | -35.86% |
| 2022 Q1 | 527 Thousand USD | 88.89% |
| 2022 FY | 171 Thousand USD | -38.71% |
| 2022 Q3 | 255 Thousand USD | -24.56% |
| 2021 Q1 | 402 Thousand USD | -15.72% |
| 2021 FY | 279 Thousand USD | -41.51% |
| 2021 Q3 | 3.44 Million USD | -4.33% |
| 2021 Q2 | 3.6 Million USD | 795.52% |
| 2021 Q4 | 279 Thousand USD | -91.9% |
| 2020 Q2 | 626 Thousand USD | -10.44% |
| 2020 FY | 477 Thousand USD | -37.89% |
| 2020 Q1 | 699 Thousand USD | -8.98% |
| 2020 Q4 | 477 Thousand USD | -13.59% |
| 2020 Q3 | 552 Thousand USD | -11.82% |
| 2019 Q3 | 837 Thousand USD | -13.62% |
| 2019 FY | 768 Thousand USD | -87.83% |
| 2019 Q4 | 768 Thousand USD | -8.24% |
| 2019 Q1 | 2.57 Million USD | -59.15% |
| 2019 Q2 | 969 Thousand USD | -62.41% |
| 2018 Q3 | 532.09 Thousand USD | 19.3% |
| 2018 Q1 | 962.35 Thousand USD | 96.96% |
| 2018 FY | 6.31 Million USD | 1191.45% |
| 2018 Q4 | 6.31 Million USD | 1085.92% |
| 2018 Q2 | 446.02 Thousand USD | -53.65% |
| 2017 Q1 | 68.15 Thousand USD | -52.57% |
| 2017 FY | 488.61 Thousand USD | 240.04% |
| 2017 Q4 | 488.61 Thousand USD | 46.71% |
| 2017 Q3 | 333.05 Thousand USD | 204.49% |
| 2017 Q2 | 109.38 Thousand USD | 60.5% |
| 2016 Q3 | 5.67 Million USD | -60.4% |
| 2016 Q4 | 143.69 Thousand USD | -97.47% |
| 2016 FY | 143.69 Thousand USD | -88.66% |
| 2016 Q2 | 14.33 Million USD | 33.27% |
| 2016 Q1 | 10.75 Million USD | 748.93% |
| 2015 Q4 | 1.26 Million USD | 0.0% |
| 2015 FY | 1.26 Million USD | -57.43% |
| 2015 Q1 | 1.99 Million USD | -33.13% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 997.75 Thousand USD | -49.86% |
| 2014 Q4 | 2.97 Million USD | -24.79% |
| 2014 FY | 2.97 Million USD | -56.67% |
| 2014 Q3 | 3.95 Million USD | -19.77% |
| 2014 Q2 | 4.93 Million USD | -16.45% |
| 2014 Q1 | 5.9 Million USD | -14.05% |
| 2013 Q2 | 8.78 Million USD | -9.77% |
| 2013 Q1 | 9.73 Million USD | 0.53% |
| 2013 Q4 | 6.86 Million USD | -12.26% |
| 2013 FY | 6.86 Million USD | -29.08% |
| 2013 Q3 | 7.82 Million USD | -10.88% |
| 2012 Q2 | 9.58 Million USD | 105.34% |
| 2012 Q4 | 9.68 Million USD | 0.53% |
| 2012 FY | 9.68 Million USD | 86.65% |
| 2012 Q1 | 4.66 Million USD | -10.04% |
| 2012 Q3 | 9.63 Million USD | 0.51% |
| 2011 Q4 | 5.18 Million USD | -8.91% |
| 2011 Q2 | 5.64 Million USD | 0.84% |
| 2011 Q3 | 5.69 Million USD | 0.87% |
| 2011 FY | 5.18 Million USD | -12.14% |
| 2011 Q1 | 5.6 Million USD | -5.17% |
| 2010 Q2 | 6.05 Million USD | -12.66% |
| 2010 Q4 | 5.9 Million USD | 1.25% |
| 2010 Q1 | 6.92 Million USD | -10.73% |
| 2010 FY | 5.9 Million USD | -23.91% |
| 2010 Q3 | 5.83 Million USD | -3.62% |
| 2009 FY | 7.76 Million USD | -43.23% |
| 2009 Q2 | 18.51 Million USD | 33.86% |
| 2009 Q4 | 7.76 Million USD | -54.34% |
| 2009 Q3 | 16.99 Million USD | -8.16% |
| 2009 Q1 | 13.82 Million USD | 1.15% |
| 2008 Q2 | 8.6 Million USD | -12.15% |
| 2008 Q4 | 13.67 Million USD | 87.57% |
| 2008 Q3 | 7.28 Million USD | -15.3% |
| 2008 FY | 13.67 Million USD | 23.17% |
| 2008 Q1 | 9.79 Million USD | -11.75% |
| 2007 FY | 11.09 Million USD | 153.5% |
| 2007 Q4 | 11.09 Million USD | 16.45% |
| 2007 Q3 | 9.53 Million USD | 0.0% |
| 2006 Q4 | 4.37 Million USD | 0.0% |
| 2006 FY | 4.37 Million USD | -47.52% |
| 2005 FY | 8.34 Million USD | 0.0% |
| 2005 Q4 | 8.34 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 99.332% |
| IceCure Medical Ltd | 599 Thousand USD | 56.26% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -42.082% |
| Acutus Medical, Inc. | 38.47 Million USD | 99.319% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 86.877% |
| Bioventus Inc. | 409.47 Million USD | 99.936% |
| BrainsWay Ltd. | 471 Thousand USD | 44.374% |
| Cerus Corporation | 95.99 Million USD | 99.727% |
| Venus Concept Inc. | 79.69 Million USD | 99.671% |
| Envoy Medical, Inc. | 404 Thousand USD | 35.149% |
| CVRx, Inc. | 30.61 Million USD | 99.144% |
| electroCore, Inc. | 626 Thousand USD | 58.147% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -359.649% |
| Inogen, Inc. | 21.92 Million USD | 98.805% |
| OrthoPediatrics Corp. | 23.76 Million USD | 98.897% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 98.283% |
| Spectral AI, Inc. | 1.28 Million USD | 79.674% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | 46.747% |
| MaxCyte, Inc. | 18.74 Million USD | 98.602% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 96.879% |
| Nexalin Technology, Inc. | 4463.00 USD | -5770.491% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.805% |
| PAVmed Inc | 48.72 Million USD | 99.462% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 96.433% |
| RxSight, Inc. | 3.01 Million USD | 91.301% |
| Sight Sciences, Inc. | 35.41 Million USD | 99.26% |
| SI-BONE, Inc. | 38.99 Million USD | 99.328% |
| TELA Bio, Inc. | 42.78 Million USD | 99.388% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 99.627% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 86.867% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 83.574% |
| LivaNova PLC | 640.4 Million USD | 99.959% |
| PetVivo Holdings, Inc. | 1.36 Million USD | 80.806% |
| Talis Biomedical Corporation | 19.66 Million USD | 98.668% |
| 908 Devices Inc. | 5.94 Million USD | 95.593% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.952% |
| Nemaura Medical Inc. | 20.03 Million USD | 98.692% |
| NeuroPace, Inc. | 72.39 Million USD | 99.638% |
| LENSAR, Inc. | 2.3 Million USD | 88.653% |
| Apyx Medical Corporation | 38.5 Million USD | 99.319% |
| Cutera, Inc. | 431.91 Million USD | 99.939% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 98.324% |
| BioSig Technologies, Inc. | 452 Thousand USD | 42.035% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 99.098% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 98.121% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.984% |
| Axonics, Inc. | 27.61 Million USD | 99.051% |
| Outset Medical, Inc. | 136.18 Million USD | 99.808% |
| IRIDEX Corporation | 2.74 Million USD | 90.459% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.669% |
| IRadimed Corporation | 2.04 Million USD | 87.176% |
| Tivic Health Systems, Inc. | 369 Thousand USD | 28.997% |
| INVO Bioscience, Inc. | 8.68 Million USD | 96.983% |
| Telesis Bio, Inc. | 34.38 Million USD | 99.238% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 97.449% |
| Varex Imaging Corporation | 469.5 Million USD | 99.944% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.735% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 88.842% |
| Pulmonx Corporation | 41.42 Million USD | 99.368% |
| Dynatronics Corporation | 6.68 Million USD | 96.083% |
| Modular Medical, Inc. | 1.19 Million USD | 77.983% |
| Semler Scientific, Inc. | 70 Thousand USD | -274.286% |
| InMode Ltd. | 9.01 Million USD | 97.094% |
| Bruker Corporation | 1.37 Billion USD | 99.981% |
| Cytosorbents Corporation | 18.31 Million USD | 98.569% |
| DexCom, Inc. | 2.59 Billion USD | 99.99% |
| Align Technology, Inc. | 96.96 Million USD | 99.73% |
| Viveve Medical, Inc. | 5.34 Million USD | 95.102% |
| ZimVie Inc. | 521.92 Million USD | 99.95% |
| Movano Inc. | 252 Thousand USD | -3.968% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 99.21% |
| Nexalin Technology, Inc. | 4463.00 USD | -5770.491% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 86.877% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.937% |
| Profound Medical Corp. | 7.9 Million USD | 96.684% |
| Insulet Corporation | 1.44 Billion USD | 99.982% |
| enVVeno Medical Corporation | 1.4 Million USD | 81.312% |
| Surmodics, Inc. | 29.4 Million USD | 99.109% |
| iCAD, Inc. | 461 Thousand USD | 43.167% |
| Nuwellis, Inc. | 981 Thousand USD | 73.293% |
| Biotricity, Inc. | 23.87 Million USD | 98.903% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.798% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 72.137% |
| InspireMD, Inc. | 1.59 Million USD | 83.574% |
| PAVmed Inc. | 48.72 Million USD | 99.462% |
| BIOLASE, Inc. | 17.91 Million USD | 98.537% |
| Beyond Air, Inc. | 17.83 Million USD | 98.531% |
| FONAR Corporation | 41.67 Million USD | 99.371% |
| AxoGen, Inc. | 69.29 Million USD | 99.622% |
| Vivani Medical, Inc. | 20.69 Million USD | 98.734% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 99.48% |
| Inari Medical, Inc. | 32.04 Million USD | 99.182% |
| UFP Technologies, Inc. | 46.03 Million USD | 99.431% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 91.469% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 74.719% |
| Tenon Medical, Inc. | 1.17 Million USD | 77.664% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 73.852% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 91.239% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.989% |
| Sintx Technologies, Inc. | 4.24 Million USD | 93.828% |
| NanoVibronix, Inc. | 5000.00 USD | -5140.0% |
| Quanterix Corporation | 41.46 Million USD | 99.368% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 88.842% |
| Sensus Healthcare, Inc. | 783 Thousand USD | 66.539% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.972% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.949% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 86.232% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -8.77% |
| Hyperfine, Inc. | 185 Thousand USD | -41.622% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.864% |
| Biomerica, Inc. | 785 Thousand USD | 66.624% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 41.711% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | 29.209% |
| Silk Road Medical, Inc | 84.63 Million USD | 99.69% |